Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
4,654 people get CVS articles and Market Currents by email alert.
Get email alerts on CVS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Aetna Appears UndervaluedDoctoRx • Thu, May 16
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 1, 2013)
-
PR Newswire (Apr 30, 2013)
-
Regulation To Drive Pharmacy SpecializationTom Luongo • Fri, Apr 26
To learn more about Seeking Alpha Pro, click here.
-
Why We Like CVS CaremarkUlfberht Capital • Mon, Apr 8
-
Earnings Analysis: CVS CaremarkCapitalCube • Wed, Nov 7, 2012
-
Watch For Walgreen-Express Scripts Impact In CVS Caremark EarningsTrefis • Mon, Nov 5, 2012
-
CVS: Demographics And Business Model Mean Tons Of Upside For The StockMike Williams • Thu, Aug 16, 2012
-
Aetna Appears UndervaluedDoctoRx • Thu, May 16
-
Regulation To Drive Pharmacy SpecializationTom Luongo • Fri, Apr 26
-
Dollar General: Full Steam Ahead?Black Coral Research • Mon, Apr 8
-
CVS Caremark's CEO Hosts 2012 Analyst Day (Transcript)Thu, Dec 13, 2012
-
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Feb 8, 2012 • 1 Comment
-
CVS Caremark Corporation - Analyst/Investor DayTue, Dec 20, 2011
-
CVS Caremark's CEO Discusses Q3 2011 Results - Earnings Call TranscriptThu, Nov 3, 2011 • 1 Comment
-
CVS Caremark Corporation Q2 2010 Earnings Call TranscriptThu, Jul 29, 2010
-
CVS Caremark Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
CVS Caremark Corporation Q4 2009 Earnings Call TranscriptMon, Feb 8, 2010
-
CVS Caremark Q3 2009 Earnings Call TranscriptThu, Nov 5, 2009
-
CVS Caremark Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
CVS Caremark Corporation Q1 2009 Earnings Call TranscriptTue, May 5, 2009
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
at Fox Business (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at Fox Business (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
PR Newswire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
PR Newswire (Apr 30, 2013)
-
at MarketWatch.com (Apr 28, 2013)
-
at CNBC.com (Apr 26, 2013)
-
at CNBC.com (Apr 20, 2013)
-
PR Newswire (Apr 19, 2013)
CVS vs. ETF Alternatives
Company Description
CVS Caremark Corporation (“CVS Caremark”, the “Company”, “we” or “us”) is the largest pharmacy health care provider in the United States. As a fully integrated pharmacy services company, we believe we can drive value for our customers by effectively managing pharmaceutical costs and improving... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, April 25, 2012, 12:08 PM CVS Caremark (CVS +1.0%) faces a lawsuit from the company that owned a container ship that sailed into the San Francisco Bay Bridge five years ago. Regal Stone and Fleet Management claims pharmacists at a CVS-unit's store recklessly sold thousands of dangerous drugs to the ship's pilot. At stake is tens of millions of dollars in damages from the 2007 accident that spilled oil into the bay. 2 Comments [Consumer]
- Monday, March 26, 2012, 3:18 PM Richard Mayo is the latest in a long line of managers who see dividends as the place to be, believing a portfolio of growth stocks will be a loser's bet in a slow-growth economic environment. A surprising source for dividends is big retailers, such as CVS, which Mayo sees as a “mature” retailing company but one churning out free cash flow of $5B-$6B/year. He also likes WMT, HD, LOW, TGT. 2 Comments [Quick Ideas]
- Thursday, March 22, 2012, 12:09 PM CVS Caremark (CVS -0.6%) has been ordered to stop controlled drug sales at two pharmacies connected to a probe on the sale of oxycodone, according to Bloomberg. Comment! [Healthcare]
- Tuesday, March 13, 2012, 12:26 PM CVS Caremark (CVS -1.3%) slips after BMO Capital downgraded the stock to Market Perform from Outperform on valuation earlier this morning. Its price target remains at $47. 3 Comments [Healthcare, On the Move]
- Tuesday, February 21, 2012, 11:48 AM The U.S. government alleges Cardinal Health (CAH) and CVS Caremark (CVS) were aware of high-volume orders of a prescription painkiller shipped to pharmacies in Florida, WSJ reports, in a case probing how much responsibility companies bear for a growing drug abuse problem. CAH failed to conduct on-site visits and often delivered more pills per month than its own limits allowed, the DEA says. 1 Comment [Healthcare]
- Wednesday, February 15, 2012, 10:56 AM CVS Caremark (CVS +1.1%) looks like a Strong Buy to SA author Takeover Analyst who sees a fair value of $53.44 (+23.8%) based on a CAGR model. Though Walgreen (WAG -1.4%) trades cheaper from a valuation standpoint, CVS' free cash flow yield of 7.8% stands 370 bps above the closest rival. Also tipping the scales toward CVS is anecdotal evidence piling in suggesting consumers are exiting away from Walgreen en masse. Will the $0.03/share benefit to bottom-line Q1 results forecast as a result of the WAG-ESRX dispute come in even higher? Comment! [Quick Ideas, Consumer]
- Wednesday, February 8, 2012, 7:10 AM More on CVS Caremark's (CVS) Q4: Retail pharmacy same store sales up 2.5% Y/Y. Pharmacy network claims processed up 46.0% Y/Y to 193M. Sees Retail segment profits increasing 8.5%-10.5% in 2012 and Pharmacy segment profits growing at a 11%-15% clip. Expects full year 2012 EPS of $3.18-$3.28. (PR) Comment! [Earnings]
- Wednesday, February 8, 2012, 6:57 AM CVS Caremark (CVS): Q4 EPS of $0.89 in-line. Revenue of $28.3B (+15.2% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Wednesday, February 8, 2012, 12:05 AM Notable earnings before Wednesday's open: AGU, AINV, AIV, AUO, CSC, CTSH, CVH, CVS, ELN, ICE, IR, LVLT, MCO, PLD, RAI, RL, S, TWX, UMC, WYN Comment! [Earnings]
- Tuesday, February 7, 2012, 5:30 PM Notable earnings before Wednesday's open: AGU, AINV, AIV, AUO, CSC, CTSH, CVH, CVS, ELN, ICE, IR, LVLT, MCO, PLD, RAI, RL, S, TWX, UMC, WYN Comment! [Earnings]
- Thursday, January 12, 2012, 12:03 PM The FTC ends its investigation into CVS Caremark (CVS +0.5%), settling with the firm for a $5M amount on charges it misrepresented Medicare prescription prices at pharmacies. (Complaint .pdf) Comment! [Consumer]
- Monday, January 9, 2012, 3:34 PM Health Net (HNT +3.3%) advances after announcing earlier it's selling its Medicare prescription-drug plan business to CVS Caremark (CVS +0.7%) for approximately $160M in an all cash deal. Comment! [Healthcare, On the Move]
- Thursday, December 22, 2011, 8:25 AM Goldman Sachs stays bullish on CVS Caremark (CVS) as it reiterates a Buy rating and tacks on dollar to lift its price target on shares to $44. Analysts with the firm call CVS a "perfect fit" for large-cap investors on the strength of a "predictable operating algorithm" and solid capital allocation. Shares +0.2% premarket. Comment! [Consumer, Quick Ideas]
- Tuesday, December 20, 2011, 4:02 PM CVS Caremark (CVS +9.2%) shares obviously benefit from its predicted double-digit profit increase in 2012 and 30% dividend hike, but it also touts the success of MinuteClinic, a wave of generics that is seen boosting profitability the next several years and customer wins if a contract spat between Walgreen (WAG) and Express Scripts (ESRX) continues into 2012. Comment! [Healthcare, On the Move]
- Tuesday, December 20, 2011, 7:54 AM CVS (CVS +2.2%) sees FY12 EPS of $3.15-3.25 vs. $3.20 consensus, and reaffirms FY11 guidance. Raises quarterly dividend 30% to $0.1625. (PR) Comment! [Earnings, Consumer, Breaking News]
- Tuesday, December 13, 2011, 4:54 PM NY Governor Andrew Cuomo signs legislation limiting the ability of PBMs such as Express Script (ESRX) and Medco Health (MHS) to guide prescriptions to mail-order pharmacies. The bill marks a victory for retail pharmacies desperate to hold on to market share with health plans. Lower on the news in AH trading: ESRX -3.7%, MHS -1.8%. Getting a lift: WAG +1%, CVS +0.7%, RAD +0.8%. 1 Comment [On the Move, Healthcare, U.S. Economy]
LATEST REPLIES




